Rochester, MN, United States of America

Jean M Lacey

This inventor holds 2 USPTO granted patents. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2008-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean M Lacey. Retrieved from https://idiyas.com/inventor/jean-m-lacey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2008-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Jean M. Lacey: A Pioneer in Pharmacogenetics

Introduction: Jean M. Lacey, an accomplished inventor based in Rochester, Minnesota, has made significant strides in the field of pharmacogenetics through her innovative research. With a total of two patents to her name, she has contributed meaningfully to the rapid determination of thiopurine methyltransferase (TPMT) activity, a crucial aspect in personalizing medical treatments for patients.

Latest Patents: Jean M. Lacey holds two noteworthy patents that focus on methods and materials related to the rapid, quantitative determination of TPMT activity in biological samples. Her patented innovations include a "Kit for Rapid Determination of Thiopurine Methyltransferase Activity," which provides essential compositions and kits that facilitate the measurement of TPMT activity. Additionally, her other patent, "Method for Rapid Determination of Thiopurine Methyltransferase Activity," outlines similar methodologies and materials aimed at streamlining the assessment process for TPMT activity in various biological samples.

Career Highlights: Jean M. Lacey is currently associated with the Mayo Foundation for Medical Education and Research, where her work continues to influence the field of pharmacogenetics. Her passion for medical research and dedication to improving patient outcomes is reflected in her innovative approaches to understanding drug metabolism, particularly concerning thiopurine drugs.

Collaborations: Throughout her career, Lacey has collaborated with esteemed colleagues such as John F. O'Brien and Mark J. Magera, enhancing the breadth and impact of her research initiatives. These partnerships have fostered an environment of collective intellectual growth, further advancing the knowledge within her specialized field.

Conclusion: Jean M. Lacey's contributions to the medical field through her patents and collaborative efforts stand as a testament to her innovative spirit and dedication. As a leader in the realm of pharmacogenetics, her work not only paves the way for personalized medicine but also inspires future generations of researchers and inventors in the pursuit of advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…